Test Price
2,800 AED✅ Home Collection Available
PLEC Gene Muscular Dystrophy, Limb‑Girdle, Type 2Q Genetic Test in the UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 certified NGS workflow with dual‑pathogenomic validation.
- Premium Home Collection: ISO‑certified cold‑chain transport (8 AM–11 PM) with a dedicated VIP mobile phlebotomist.
- Post‑Test Clinical Guidance: Complimentary tele‑consultation with DHA‑licensed genetics specialist for result interpretation.
- Direct Insurance Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
PLEC‑related limb‑girdle muscular dystrophy type 2Q (LGMD2Q) is an autosomal recessive myopathy caused by biallelic mutations in the plectin gene. This NGS test delivers definitive molecular diagnosis for affected individuals, carrier screening for at‑risk family members, and prognostic insight.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Methodology | Full‑gene NGS with CNV analysis | Single‑gene Sanger sequencing (limited) |
| Turnaround | 3–4 weeks | 6–8 weeks |
| Home Collection | 8 AM–11 PM, ISO cold chain | Clinic visit only |
Pre‑test requirement: A detailed clinical history and, where possible, a genetic counselling session to construct a family pedigree for limb‑girdle muscular dystrophy type 2Q.
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Genetics, I urge patients and families to view this genetic test as a map, not a sentence. A positive PLEC mutation confirms the cause of weakness, but clinical correlation with EMG, creatinine kinase, and muscle biopsy is still essential. We walk this journey with you – from initial counselling through post‑test interpretation – always prioritizing emotional support and precise medical planning.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403
Medication Safety Advisory
⚠ Do not discontinue any prescribed medication (e.g., corticosteroids, immunosuppressants, or cardiac drugs) before or after the test without direct consultation with your treating physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent (minors require a legal guardian). Active bleeding disorder or therapeutic anticoagulation not optimized for phlebotomy.
- Red Flags — Seek Emergency Care if: You develop expanding hematoma, uncontrolled bleeding, fainting, or signs of infection (fever, redness, pus) at the blood draw site after home collection.
- Genetic results that reveal incidental findings of life‑threatening significance will be communicated urgently by a specialist via phone, with an automatic appointment for a follow‑up clinic consultation.
Patient FAQ & Clinical Guidance
1. What is the PLEC gene and how does it cause limb‑girdle muscular dystrophy type 2Q?
The PLEC gene encodes plectin, a cytoskeletal linker protein critical for muscle fibre integrity – biallelic pathogenic variants lead to LGMD2Q.
2. Who should consider this PLEC Genetic Test in the UAE?
Any individual with progressive proximal muscle weakness, positive family history, or elevated CK plus myopathic EMG should be offered this test.
3. What does UAE law say about genetic testing in minors for muscular dystrophy?
Under Federal Decree-Law No. 4 of 2016 on Medical Liability, predictive genetic testing for healthy minors is prohibited unless a DHA‑accredited genetic counsellor confirms imminent medical benefit – parental consent is mandatory.
4. How should I prepare for the blood collection?
No special preparation is needed. Maintain normal hydration. If you are on anticoagulants, inform the phlebotomist. The sample can be collected at home between 8 AM and 11 PM.
UAE Regulatory & Data Privacy Adherence
Data Protection: Your genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All results are encrypted, access‑controlled, and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | PLEC Gene Sequencing (Limb‑Girdle Muscular Dystrophy Type 2Q) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card blood spot |
| Methodology Used | Next‑Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 82162-1 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians